These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9034749)

  • 1. Automated rescreening of Papanicolaou smears.
    Ciatto S
    Diagn Cytopathol; 1997 Jan; 16(1):98-9. PubMed ID: 9034749
    [No Abstract]   [Full Text] [Related]  

  • 2. Rescreening of cervical Papanicolaou smears using PAPNET.
    Schechter CB
    JAMA; 1998 Jun; 279(22):1787; author reply 1787-8. PubMed ID: 9628708
    [No Abstract]   [Full Text] [Related]  

  • 3. Rescreening of cervical Papanicolaou smears using PAPNET.
    Mango LJ; Radensky PW
    JAMA; 1998 Jun; 279(22):1786-7; author reply 1787-8. PubMed ID: 9628707
    [No Abstract]   [Full Text] [Related]  

  • 4. Automation in cytology: a survey conducted by the New Technology Task Force, Papanicolaou Society of Cytopathology.
    Masood S; Cajulis RS; Cibas ES; Wilbur DC; Bedrossian CW
    Diagn Cytopathol; 1998 Jan; 18(1):47-55. PubMed ID: 9451558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated rescreening of Papanicolaou smears: what are the implications?
    Birdsong GG
    Diagn Cytopathol; 1995 Nov; 13(4):283-6. PubMed ID: 8599909
    [No Abstract]   [Full Text] [Related]  

  • 6. Automation in cervical cytology: an overview.
    Banda-Gamboa H; Ricketts I; Cairns A; Hussein K; Tucker JH; Husain N
    Anal Cell Pathol; 1992 Jan; 4(1):25-48. PubMed ID: 1734941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy.
    O'Leary TJ; Tellado M; Buckner SB; Ali IS; Stevens A; Ollayos CW
    JAMA; 1998 Jan; 279(3):235-7. PubMed ID: 9438746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescreening of cervical Papanicolaou smears using PAPNET.
    Koss LG
    JAMA; 1998 Jun; 279(22):1786; author reply 1787-8. PubMed ID: 9628706
    [No Abstract]   [Full Text] [Related]  

  • 9. Automated screening of pap smears: a statement of caution.
    Medley G; Laverty CR; Fortune DW; Baird PJ; Smith LA; Papadimos DJ; Sterrett GF; Carter CD; Wright RG; Twin JE; Grace J; Bishop JM
    Med J Aust; 1996 Feb; 164(3):187. PubMed ID: 8628141
    [No Abstract]   [Full Text] [Related]  

  • 10. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
    Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
    Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative utility of repeat Papanicolaou smears, cervicography, and colposcopy in the evaluation of atypical Papanicolaou smears.
    Spitzer M; Krumholz BA; Chernys AE; Seltzer V; Lightman AR
    Obstet Gynecol; 1987 May; 69(5):731-5. PubMed ID: 3106869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescreening of cervical Papanicolaou smears using PAPNET.
    Greenberg MD
    JAMA; 1998 Jun; 279(22):1785-6; author reply 1787-8. PubMed ID: 9628705
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of false-negative Papanicolaou smears by rapid rescreening in a large routine cervical cytology laboratory.
    Wright RG; Halford JA; Ditchmen EJ
    Pathology; 1999 Nov; 31(4):379-81. PubMed ID: 10643010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stanley F. Patten, Jr., M.D., Ph.D. and the development of an automated Papanicolaou smear screening system.
    Lee JS; Nelson AC
    Cancer; 1997 Dec; 81(6):332-6. PubMed ID: 9438457
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
    Leidy NK; Brown R; Luce B; Sheets E
    JAMA; 1999 Oct; 282(15):1419; author reply 1420. PubMed ID: 10535423
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
    Sedlacek TV
    JAMA; 1999 Oct; 282(15):1419-20. PubMed ID: 10535424
    [No Abstract]   [Full Text] [Related]  

  • 17. Automatic analysis of Papanicolaou smears by digital image processing.
    Stenkvist B; Bergström R; Brinne U; Hesselius I; Kiviranta A; Nordgren H; Schnürer L; Stendahl U; Sténson S; Söderström J
    Gynecol Oncol; 1987 May; 27(1):1-14. PubMed ID: 3570043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of bacterial vaginosis in wet mount, Papanicolaou stained vaginal smears and in gram stained smears.
    Platz-Christensen JJ; Larsson PG; Sundström E; Wiqvist N
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):67-70. PubMed ID: 7856436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical squamous cells of undetermined significance: a comparative review of original and automated rescreen diagnosis of cervicovaginal smears with long term follow-up.
    Stastny JF; Remmers RE; London WB; Pedigo MA; Cahill LA; Ryan M; Frable WJ
    Cancer; 1997 Dec; 81(6):348-53. PubMed ID: 9438460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does cost-effectiveness analysis make a difference? Lessons from Pap smears. Symposium.
    Hagen MD; Garber AM; Goldie SJ; Lafata JE; Mandelblatt J; Meltzer D; Neumann P; Siegel JE; Sox HC; Tsevat J
    Med Decis Making; 2001; 21(4):307-23. PubMed ID: 11475387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.